Author

Pio Conti

Professor of Immunology, University of Chieti, Affiliated Professor, TUFTS University, Boston - Cited by 17,572 - Immunology - Inflammation - Medicine - Biology

Biography

Pio Conti works in the Immunology Division, Postgraduate Medical School, University of Chieti-Pescara, Chieti, Italy. International experience includes various programs, contributions and participation in different countries for diverse fields of study.
Title
Cited by
Year
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies
P Conti, G Ronconi, AL Caraffa, CE Gallenga, R Ross, I Frydas, SK KritasJ Biol Regul Homeost Agents 34 (2), 327-331, 20201805202
1805
2020
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy
SK Kritas, G Ronconi, AL Caraffa, CE Gallenga, R Ross, P ContiJ Biol Regul Homeost Agents 34 (1), 9-14, 2020202
283
2020
Dexamethasone for COVID-19? Not so fast
TC Theoharides, P ContiJ Biol Regul Homeost Agents 34 (3), 1241-1243, 2020202
172
2020
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1
E Toniato, R Ross, SK KritasJ Biol Regul Homeost Agents 34 (2), 11-16, 2020202
162
2020
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem
P Conti, A Caraffa, CE Gallenga, SK Kritas, I Frydas, A Younes, ...J Biol Regul Homeost Agents 35 (1), 1-4, 2021202
148
2021
Progression in migraine: role of mast cells and pro-inflammatory and anti-inflammatory cytokines
P Conti, C D’Ovidio, C Conti, CE Gallenga, D Lauritano, A Caraffa, ...European journal of pharmacology 844, 87-94, 2019201
105
2019
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19
P Conti, A Caraffa, G Tetè, CE Gallenga, R Ross, SK Kritas, I Frydas, ...J. Biol. Regul. Homeost. Agents 34 (5), 1629-1632, 2020202
99
2020
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy
P Conti, A Caraffa, CE Gallenga, R Ross, SK Kritas, I Frydas, A Younes, ...J Biol Regul Homeost Agents 34 (6), 1971-5, 2020202
92
2020
Interleukin-1 family cytokines and mast cells: activation and inhibition
CE Gallenga, F Pandolfi, A Caraffa, SK Kritas, G Ronconi, E Toniato, ...J Biol Regul Homeost Agents 33 (1), 1-6, 2019201
90
2019
Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin
A Taracanova, I Tsilioni, P Conti, ER Norwitz, SE Leeman, ...Proceedings of the National Academy of Sciences 115 (40), E9381-E9390, 2018201
76
2018
COVID-19 induced by SARS-CoV-2 causes Kawasaki-like disease in children: Role of pro-inflammatory and anti-inflammatory cytokines
R Ross, P ContiJ. Biol. Regul. Homeost. Agents 34 (3), 767-773, 2020202
71
2020
The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders
J Di Gregorio, I Robuffo, S Spalletta, G Giambuzzi, V De Iuliis, E Toniato, ...Frontiers in Cell and Developmental Biology 8, 607483, 2020202
69
2020
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra)
P Conti, A Caraffa, CE Gallenga, R Ross, SK Kritas, I Frydas, A Younes, ...J Biol Regul Homeost Agents 34 (5), 1623-1627, 2020202
64
2020
COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome
TC Theoharides, P ContiJ Biol Regul Homeost Agents 34 (5), 1633-6, 2020202
59
2020
Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury
S Mammana, A Gugliandolo, E Cavalli, F Diomede, R Iori, R Zappacosta, ...Journal of tissue engineering and regenerative medicine 13 (7), 1109-1121, 2019201
54
2019
Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37
P Conti, D Lauritano, A Caraffa, CE Gallenga, SK Kritas, G Ronconi, ...European journal of pharmacology 875, 173035, 2020202
48
2020
IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin
I Tsilioni, AB Patel, H Pantazopoulos, S Berretta, P Conti, SE Leeman, ...Proceedings of the National Academy of Sciences 116 (), 21659-21665, 2019201
43
2019
IL-1 superfamily members and periodontal diseases
E Papathanasiou, P Conti, F Carinci, D Lauritano, TC TheoharidesJournal of Dental Research 99 (13), 1425-1434, 2020202
39
2020
Be aware of SARS-CoV-2 spike protein: There is more than meets the eye
TC Theoharides, P ContiJ Biol Regul Homeost Agents 35 (3), 833-8, 2021202
38
2021
Mast cell cytokines IL-1, IL-33, and IL-36 mediate skin inflammation in psoriasis: a novel therapeutic approach with the anti-inflammatory cytokines IL-37, IL-38, and IL-1Ra
P Conti, FE Pregliasco, RG Bellomo, CE Gallenga, A Caraffa, SK Kritas, ...International Journal of Molecular Sciences 22 (15), 8076, 2021202
34
2021

Referred From: https://scholar.google.co.uk/citations?user=gzoVZ9MAAAAJ&hl=it

Cited by
Citations 17572
h-index 65
i10-index 280
Open Access Journals